Trying to gauge AI's in healthcare fields

Artificial intelligence (AI) is a hot topic across medical fields, from handling information technology to its impact in imaging. In an interview with Forbes, Nuance Communications executive vice president and general manager Satish Maripuir discussed its potential to affect various areas in healthcare.

AI has improved dramatically over the years to pinpoint disease areas, predict the onset of infectious diseases and streamlining workflow but Maripuri believes this is just the tip of the iceberg.

“The impact AI will have on healthcare comes from a new and expanded use of AI-powered solutions, such as conversational virtual assistants combined with mobility. It’s in this area that you begin to see highly intelligent systems that can act in partnership with human intelligence in powerful ways,” Maripuir told Forbes. “What’s key here is that the interaction is natural and an integrated part of a physician’s regular workflow. That’s not only solving problems but opening avenues for improved diagnoses and treatments.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.